All In MedTech

Device Trial Radar · NCT07189013

Assessing Patient Preference for Infusion Systems

Assessing Patient Preference for Infusion Systems (Electronic vs. Mechanical)

Last checked: Nov 20, 2026Latest source record: Sep 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

52

Planned (sponsor's estimate)

Start

Oct 15, 2025

Primary completion

Mar 2026

Study completion Apr 2026

Sponsor

Lead sponsor
KORU Medical Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 23, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This crossover study evaluates patient experiences and preferences between mechanical and electrical infusion pumps for subcutaneous immunoglobulin (SCIg) therapy. The Freedom Integrated Infusion System (FREEDOM60 and FreedomEdge) are mechanical, portable pumps that require no batteries or electricity and use Precision Flow Rate Tubing™ to control infusion speed. These devices are approved for use in the EU (CE650520). Approximately 78 adult patients with primary or secondary immunodeficiency will participate. Participants will complete questionnaires assessing ease of training, ease of use, infusion comfort, and overall satisfaction. Patients experienced with electronic pumps will complete two questionnaires: one reflecting their current pump experience and one after trying the mechanical pump. The primary goal is to determine whether mechanical pumps provide greater patient satisfaction than electrical pumps. Results will inform patient and healthcare professional decision-making regarding pump selection.

Conditions

  • Primary Immunodeficiencies (PID)
  • Secondary Immunodeficiencies (SID)

Interventions

  • Mechanical infusion pumpDevice

    Patients with earlier experience on electronic infusion pumps will crossover to the mechanical infusion pump for three month's period

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Patient Satisfaction Scores Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 MonthsTime frame: Three months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • King's College Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.